Matthias Paschke

This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Baxalta Gmbh, 3B Pharmaceuticals Gmbh, Scil Proteins Gmbh. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Paschke. Retrieved from https://idiyas.com/inventor/matthias-paschke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 6)

% Patents Active = 71.4

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 15)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

3B Pharmaceuticals Gmbh

Shire Orphan Therapies Gmbh

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734259 - COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF (2026-09-15),

2. 12427210 - Compounds comprising a fibroblast activation protein ligand and use thereof (2025-09-30),

3. 10799605 - Conjugate comprising a neurotensin receptor ligand and use thereof (2020-10-13),

4. 10124033 - Peptides and methods of use (2018-11-13),

5. 9447147 - Peptides and methods of use (2016-09-20),

6. 8629088 - Mixture of at least two fusion proteins, the production thereof and the use of the same (2014-01-14),

7. 8410134 - 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators (2013-04-02),

Title: Matthias Paschke: Innovator in Biopharmaceuticals

Introduction

Matthias Paschke is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biopharmaceuticals, holding a total of 7 patents. His work focuses on innovative compounds and their applications in medical science.

Latest Patents

Among his latest patents is a compound comprising a fibroblast activation protein ligand and its use. This invention relates to a compound that includes a cyclic peptide and a chelator, showcasing his expertise in developing novel therapeutic agents. Another notable patent is a conjugate comprising a neurotensin receptor ligand, which details a complex structure designed for targeted binding to specific biological targets. This invention emphasizes the intricate design of targeting moieties and adapter moieties, highlighting his innovative approach to drug development.

Career Highlights

Throughout his career, Matthias has worked with notable companies such as Baxalta GmbH and 3B Pharmaceuticals GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Matthias has collaborated with esteemed colleagues, including Frank Osterkamp and Ulrich Reineke. These partnerships have further enhanced his research capabilities and have led to significant advancements in his field.

Conclusion

Matthias Paschke is a distinguished inventor whose work in biopharmaceuticals continues to impact the industry. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.